Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Restructuring Costs (2020 - 2022)

Historic Restructuring Costs for Solid Biosciences (SLDB) over the last 3 years, with Q2 2023 value amounting to -$63000.0.

  • Solid Biosciences' Restructuring Costs fell 10414.47% to -$63000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $5.6 million, marking a year-over-year decrease of 2205.35%. This contributed to the annual value of -$63000.0 for FY2023, which is 10087.77% down from last year.
  • Latest data reveals that Solid Biosciences reported Restructuring Costs of -$63000.0 as of Q2 2023, which was down 10414.47% from $5.7 million recorded in Q4 2022.
  • Solid Biosciences' 5-year Restructuring Costs high stood at $5.7 million for Q4 2022, and its period low was -$63000.0 during Q2 2023.
  • Moreover, its 3-year median value for Restructuring Costs was $1.7 million (2020), whereas its average is $2.3 million.
  • Within the past 5 years, the most significant YoY rise in Solid Biosciences' Restructuring Costs was 10414.47% (2023), while the steepest drop was 10414.47% (2023).
  • Over the past 3 years, Solid Biosciences' Restructuring Costs (Quarter) stood at $1.9 million in 2020, then skyrocketed by 191.05% to $5.7 million in 2022, then plummeted by 101.11% to -$63000.0 in 2023.
  • Its last three reported values are -$63000.0 in Q2 2023, $5.7 million for Q4 2022, and $1.5 million during Q2 2022.